Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
In this study, a selective and multi-stages screening for neurodevelopmental disorders (NDD) in siblings of children with a confirmed ASD is done. The main aims are to estimate the prevalence of NDD among siblings and to evaluate the feasibility and acceptability of a standardized screening procedure.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 16
Healthy Volunteers: f
View:
• Step 1: Brothers or sisters (including stepsisters and brothers); aged between 2 and 16 years; living in Occitanie; informed and express consent of parents ; affiliated to social security.
• Step 2: step 1 positive screening or parental concerns for child's development ; parental signed informed consent.
Locations
Other Locations
France
Chu Montpellier
RECRUITING
Montpellier
Contact Information
Primary
Cécile MICHELON
c-michelon@chu-montpellier.fr
467330986
Backup
Charlotte GERBE
charlotte.gerbe@chu-montpellier.fr
Time Frame
Start Date: 2023-11-28
Estimated Completion Date: 2026-11
Participants
Target number of participants: 384
Treatments
neurodevelopmental disorders
Step 1 - Screening: the targeted sample is the siblings of the autistic children, these siblings being at risk of neurodevelopmental disorders.~Step 2 - Clinical interview: All the children with a positive screening.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Montpellier
Collaborators: Direction Générale de l'Offre de Soins